4

PRIMARY DOCUMENT

Company: ENDONOVO THERAPEUTICS, INC.
Filed: July 7, 2020
Period of Report: June 30, 2020
Accession Number: 0001645470-20-000005

View Document ↗ View on SEC.gov ↗